Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001949846-24-000179
Filing Date
2024-03-28
Accepted
2024-03-28 08:34:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2780
  Complete submission text file 0001949846-24-000179.txt   4281
Mailing Address 61 MOULTON ST CAMBRIDGE MA 02138
Business Address
MISSLING CHRISTOPHER U (Reporting) CIK: 0001196573 (see all company filings)

Type: 144

Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Subject) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: 144 | Act: 33 | File No.: 001-37606 | Film No.: 24793712
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)